Skip to main content
Surender Grover on Muck Rack

Surender Grover

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Surender

Contact Surender, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Should pregabalin be regulated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act of India?

|
By Atul Ambekar, Priyanka Saha, Surender Grover, Jadeer K. Muhammed
| The Lancet Verified
Pregabalin is a gabapentinoid which was initially used as an adjuvant in antiepileptic treatment for partial seizures and later gained US FDA approval for its use in neuropathic pain in 2004.1 In India, Pregabalin is not included in Schedule H1 of the Drugs and Cosmetics Rules, which require strict monitoring and record-keeping of prescriptions to prevent abuse. It is also not considered a narcotic or psychotropic medication under India's NDPS Act.
Open in Who Shared Issue with article?
See all 1 articles